Needham Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $58

Benzinga · 2d ago
Needham analyst Mike Matson initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $58.